VOYA Investment Management
IRLA

VOYA Investment Management’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

VOYA Investment Management’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39
Closed -$714K – 2816
2021
Q3 		$714K Sell
39
-1
-3% -$15.9K ﹤0.01% 1813
2021
Q2 		$419K Buy
40
+6
+18% +$50.3K ﹤0.01% 2197
2021
Q1 		$243K Buy
+34
New +$245K ﹤0.01% 2432
2020
Q4 		– Sell
-27
Closed -$274K – 2691
2020
Q3 		$274K Hold
27
– – ﹤0.01% 1992
2020
Q2 		$253K Sell
27
-2
-7% -$18.3K ﹤0.01% 2048
2020
Q1 		$264K Buy
29
+1
+4% +$9.87K ﹤0.01% 1982
2019
Q4 		$311K Buy
+28
New +$169K ﹤0.01% 2161

Other funds holding IRLA

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

VOYA Investment Management's IRLA Position: Q4 2021 in Review

VOYA Investment Management sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q4 2021, closing a stake of 39 shares — an estimated $714K sold.

VOYA Investment Management first reported a position in IRLA in Q4 2019 and held it in 7 quarters. The position peaked at $714K in Q3 2021. 98 funds tracked by Wall St. Rank hold IRLA as of Q4 2021.

  • VOYA Investment Management reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • VOYA Investment Management sold 39 IRulya Therapeutics Inc. Common Stock shares in Q4 2021, an estimated $714K.
  • VOYA Investment Management first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • VOYA Investment Management's IRulya Therapeutics Inc. Common Stock position peaked at $714K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q4 2021.

Based on VOYA Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.